Der Gewinn pro Aktie von Bausch + Lomb übertraf die Erwartungen um 60 %. Das Umsatzwachstum wurde durch einen Anstieg von 6 % im Jahresvergleich getragen. Der Aktienkurs fiel trotz der starken Ergebni ...

Eyecare company Bausch + Lomb (NYSE:BLCO) announced in Q1 CY2026, with sales up 9.4% year on year to $1.24 billion. The ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S.

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.07 per share a year ago. These figures ...

The Financial Times reported Bausch + Lomb is in talks with advisors to potentially sell itself. It had formerly sought to spin off from parent Bausch Health in a stock-for-stock deal. But Bausch ...

Twenty-one months into his second tenure as CEO of Bausch + Lomb, serial dealmaker Brent Saunders has so far come up empty in his latest attempt to sell the company. But it hasn’t been for lack of ...

This summer, Bausch + Lomb unveiled plans to acquire a dry eye disease treatment from Novartis for up to $2.5 billion. Now, the eye health company has closed the deal. The purchase of XIIDRA, a 5% a ...

Ratings for Bausch & Lomb (NYSE:BLCO) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...

(a) The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current ...

Eye health products company Bausch + Lomb is teaming up with Walmart to host eye care clinics at dozens of the retailer’s stores nationwide. “Eye Care for My Care” aims to help educate shoppers on the ...

Bausch + Lomb has teamed up with American sportscaster Erin Andrews to promote its dry eye disease treatment, launching the “Miebo ohh yeah” campaign to spread the word about the condition and drug.

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...